The hypothesized impact of ACE2 levels on disease severity was validated by the moderate to strong positive correlation between the ACE2 serum levels and ROS (r = 0.532–0.739) and RNS (r = 0.595–0.638) in COVID-19 patients. Here, ACE2 is linked to COVID-19.